What does real-time spine market intelligence actually look like? Every day, SmartTRAK's expert analysts monitor every critical development across the global spine landscape, cutting through the noise so Medtech leaders don't miss a beat. As a preview of what our platform delivers daily, including real-time updates, comprehensive market coverage and simple-to-use tools, we’re sharing a select sampling of recent updates posted ahead of NASS 2026.
Attending NASS 2026 from October 14–17? We’d love to connect with you in person. Click the button below to schedule time with us and learn how SmartTRAK can strengthen your team’s market strategy.
Here is a sample of what SmartTRAK delivers every day in real time:
Market Updates:
- Integrated Enabling Platforms Raise the Stakes in Spine
In Q226, MDT’s Stealth AXiS drove nav growth, GMED gained CE Mark for Excelsius3D, and OFIX advanced VIRATA MIS toward full launch. These moves reinforce robotics, navigation and integrated platforms as key drivers of vendor conversion and competitive share. Q226 Spine Mkt Recap - CMS FY27 Could Accelerate Custom Lumbar Interbody Adoption
SmartTRAK anticipates that CMS FY27 reimbursement may broaden adoption of custom lumbar interbody devices, as GMED’s SCRIPT joins Carlsmed and DeGen, elevating virtual planning and additive manufacturing as key competitive capabilities. Q226 US Spine Market Recap - GMED Confident w/ Spine Growth Continuing
GMED mgmt attributes its 5th consecutive quarter of above-market Spine growth to multiple drivers, including competitive rep additions, DuraPro power tools (+250% in Q2), and DD growth in SABLE, ELSA, HEDRON C and Reline products. WF Healthcare Conference - Medtronic Focuses on Personalized Therapy at Scale
MDT’s broader strategy centers on personalizing therapy at scale, including pt-specific surgical planning in Spine. Mgmt views robotics and other enabling tech as key to delivering more integrated, customized procedural workflows. MDT WFHC Transcript on Seeking Alpha
Clinical/Regulatory:
- Xenix Brings Osteogenic Nanotechnology to Spinopelvic Fixation
Xenix received FDA clearance for Riva Anchor, the first spinopelvic system w/ an FDA nanotechnology designation. Its NanoACTIV micro/nano surface is designed to promote osteogenic response.
- Globus Medical received CE marking for the Excelsius3D, enabling commercialization in the EU and UK. The 3-in-1 imaging system expands the Excelsius enabling technology ecosystem and enhances ExcelsiusGPS robotic navigation capabilities.
- INTRASPINE - Cousin Biotech
This 50-pt observational study will evaluate the performance and safety of the IntraSPINE Interlaminar device for the tx of DDD. This is an extension of a prospective study conducted between 2012 and 2017. Est completion date is June 2031. clinicaltrials.gov - MySpine - Medacta
A 130-pt observational study will evaluate the safety and neurophysiological performance of pt-specific MySpine guides for pedicle screw placement in pts undergoing instrumented spinal surgery. Est completion date is Dec 2026. clinicaltrials.gov
Patents:
- Spinal Simplicity
Spinal Simplicity’s US Patent Application “STRUT IMPLANT FOR SUPPORTING SPINAL IMPLANT CONSTRUCTS” was published describing a strut for a short-segment construct that prevents implant failure due to improvements to pedicle screw-rod constructs. 20260283653 - Globus
Globus Medical’s US Patent Application “SHANK AND TULIP ASSEMBLIES FOR SPINAL SURGERY” was published describing an assembly for a surgical implant procedure for the SI joint that includes a fusion shank w/ features that foster bone fusion. 20260283652 - Life Spine
Life Spine’s US Patent Application “BOTTOM LOADING POLY-AXIAL SCREW” was published, describing a modular polyaxial bone screw that includes a polyaxial tulip head and a collet configured to lock the orientation of the tulip head on and relative to the bone screw. 20260283650 - Intervertebral Spacer That Dynamically Promotes Bone Growth
A US Patent Application “INTERVERTEBRAL SPACER THAT DYNAMICALLY PROMOTES BONE GROWTH,” submitted by Simply Medical of San Diego, CA, was published describing intervertebral spacers for dynamically promoting bone growth and fusion. 20260272671
Deals/Financing:
- DePuy Synthes Acquires Expanding Innovations
DePuy Synthes announced the acquisition of Expanding Innovations. This acquisition expands DePuy Synthes’ portfolio in the expandable interbody cage mkt w/ Expanding Innovations' non-screw-based expandable cage technology. - Medtronic
MDT announced its intent to acquire temporary peripheral PNS company SPR Therapeutics for an upfront cash payment of ~$650MM w/ an expected close in MDT’s H1FY27. The companies will continue to operate as separate and independent companies until the deal closes. - Aurora Renews SiLO TFX Patent License, Resolves Royalty Dispute Aurora Spine entered a new four-year license w/ SILIF covering technology used in its SiLO TFX SI Joint System. The agreement resolves a royalty dispute, includes a $283K payment and simplifies future SiLO TFX royalties.
- Imperative Care
Imperative Care closed an oversubscribed $100MM financing round with both new and existing investors participating. Proceeds will support the commercialization of existing thrombectomy products, the development of the Telos robotic platform and clinical evidence generation.
Studies:
- Lateral Mass Gutter Improves Cervical Laminoplasty Outcomes
In 105 cervical laminoplasty pts, a lateral mass gutter technique increased canal expansion and hinge fusion while reducing hinge fractures vs conventional guttering. Neurologic recovery also improved, w/o higher complication rates. GSJ - Penumbra
Penumbra announced that it has initiated the FORWARD Study to evaluate mechanical thrombectomy and CAVT with its RED catheters and THUNDERBOLT in distal M2 occlusions. The first of 250 patients worldwide was enrolled by Dr. Keith Woodward in Knoxville, TN. - MIS-OTIF Extends Minimally Invasive Fusion Into Thoracic Spine
In 25 thoracic/TL cases, MIS oblique thoracic interbody fusion showed efficient operative times, low complications and feasibility in obese and revision pts, w/ no conversions to open thoracic surgery. Findings support expanding MIS fusion into more complex pathology. Cureus - MILD- Stryker
In 182 LSS pts, MILD produced no MRI evidence of anatomical decompression or SedSign improvement, while open decompression achieved 100% SedSign reversal and > 90% ligamentum flavum removal, raising questions about MILD’s ability to address central stenosis. Spine J
Want to learn more about SmartTRAK’s Spine coverage while at NASS 2026, including how to get up-to-date intelligence on spine industry trends, news, financial data and competitor developments? To find out how SmartTRAK can work for you, just click the button below.
SmartTRAK is the Medtech industry’s only global Insights-as-a-Service solution for the Orthopedics, Wound Care, Regenerative Medicine and Neuro Therapy markets. SmartTRAK’s proprietary methodology turns disparate data from hundreds of sources into powerful insights customers can rely on as the trusted source for strategic decision-making. The SmartTRAK enterprise platform includes rich daily updates, comprehensive market coverage and simple-to-use tools and dashboards for market, product and financial analysis. Customers leveraging the SmartTRAK platform also have direct access to market experts for inquiries and advisory services. If you would like a demo of what SmartTRAK offers and how we can help increase proficiency, improve productivity and reduce costs for your company, just click here.
